Skip to content
← Lobby Directory
AP
OtherAcadia

Acadia Pharmaceuticals GmbH

Zug, SWITZERLANDPharmaceutical companyReg: 9760680100277-26Since 11/09/2025

Budget

€100 — €0

EP Access

0

accredited persons

Staff

3

0.6 FTE

EU Grants

None

Mission & Goals

At Acadia, we are committed to developing therapies in areas with high unmet needs, elevating life to ensure a brighter future for all. United in our commitment, we strive for a healthier tomorrow—embracing diverse perspectives, fostering collaboration, and standing resilient in our mission to elevate life with unwavering dedication.

EU Legislative Interests

Health Care Policy

Communication Activities

Rett Disease Policy Forum event to be organized in European Parliament on Dec 4th coordinated by CRA International Inc. with MAP member as part of faculty as well. Including writing and release of White paper around generalized healthcare of Rett Syndrome across Europe.

Interests Represented

Promotes their own interests or the collective interests of their members

Member Of

EURORDIS Rett Syndrome Europe EUCOPE BIOEUROPE EFPIA ISPOR

Commissioner Meetings

No recorded meetings with EU commissioners.